There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...
The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...
18h
HealthDay on MSNGLP-1 RA Use Tied to Better Kidney Transplant Outcomes in Patients With DiabetesGlucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with better graft and patient survival among k ...
21h
MarketBeat on MSNIs Viking Therapeutics the Next Blockbuster GLP-1 Stock?When it comes to clinical weight-loss treatments, GLP-1 therapies have taken the medical sector by storm. What started as off ...
GLP-1 medications are changing the way we approach weight loss and chronic conditions. Dr. Nima Mowzoon of UBI Telehealth ...
GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.
People with a higher sense of purpose experience a 46% lower mortality risk and are 33% less likely to develop sleep problems.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results